Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Transgenomic acquires clinical sample biorepository from Gene Logic
July 2012
SHARING OPTIONS:

OMAHA, Neb.Transgenomic Inc. announced last month that it has entered into an agreement with Gene Logic Inc., an Ocimum Biosolutions company, to acquire its biorepository assets for $250,000 in cash. The biorepository contains thousands of human biological samples that can be used to validate diagnostic assays developed by Transgenomic.  
 
Transgenomic will use the samples to develop and validate its REVEAL family of proprietary ICE COLD-PCR-based oncology assays, as well as its WAVE MCE System and SURVEYOR Scan Mutation Detection Kits.  
 
The Gene Logic biorepository consists of a high-quality, diverse collection of human tissue samples and extracted DNA specimens with linked clinical information. The 60,000 samples and specimens cover multiple disease areas, including many thousands of cancer tissue specimens.
 
"This transaction significantly strengthens Transgenomic's position in translational medicine services, providing a deep source of clinical samples allowing us to validate new drug-associated genetic targets," said Craig Tuttle, CEO of Transgenomic. "The biorepository provides not only strategic and operational benefits, but also long-term cost savings. Acquiring specimens on a case-by-case basis is expensive and time-consuming; such expenditure would quickly surpass the cost of acquiring this asset."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.